|
response to other organism
|
GO:0051707 |
261 |
0.969
|
Human Mouse |
|
defense response to virus
|
GO:0051607 |
71 |
0.962
|
Human |
|
multi organism cellular process
|
GO:0044764 |
156 |
0.960
|
Human |
|
innate immune response
|
GO:0045087 |
178 |
0.945
|
Human Mouse |
|
immune response
|
GO:0006955 |
307 |
0.936
|
Human Mouse |
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.923
|
Human Mouse |
|
defense response
|
GO:0006952 |
315 |
0.921
|
Human Mouse |
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.913
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
35 |
0.885
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.874
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.872
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.864
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.846
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.846
|
Human |
|
positive regulation of interferon beta production
|
GO:0032728 |
17 |
0.839
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.823
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.788
|
Human |
|
regulation of viral process
|
GO:0050792 |
103 |
0.788
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.779
|
Human |
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.761
|
Human Mouse |
|
response to virus
|
GO:0009615 |
126 |
0.725
|
Human Mouse |
|
regulation of defense response
|
GO:0031347 |
154 |
0.714
|
Human |
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.709
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.704
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.699
|
Human |
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.697
|
Human |
|
activation of innate immune response
|
GO:0002218 |
55 |
0.688
|
Human |
|
viral process
|
GO:0016032 |
146 |
0.670
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.661
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.660
|
Human |
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.647
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.628
|
Human |
|
regulation of viral genome replication
|
GO:0045069 |
48 |
0.621
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.594
|
Human |
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.541
|
Human |
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.445
|
Human |
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.423
|
Human |
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
8 |
0.420
|
Human |
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.411
|
Human |
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.369
|
Human |
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.368
|
Human |
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.361
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.322
|
Human |
|
regulation of response to biotic stimulus
|
GO:0002831 |
55 |
0.321
|
Human |
|
activation of immune response
|
GO:0002253 |
114 |
0.310
|
Human |
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.307
|
|
|
regulation of mda 5 signaling pathway
|
GO:0039533 |
4 |
0.253
|
Human |
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.251
|
Human |
|
regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039531 |
7 |
0.250
|
Human |
|
glycosylation
|
GO:0070085 |
71 |
0.249
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.216
|
Human |
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.200
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.198
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.193
|
Human |
|
protein import into nucleus
|
GO:0006606 |
104 |
0.183
|
Human |
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.176
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.174
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.173
|
|
|
rig i signaling pathway
|
GO:0039529 |
7 |
0.170
|
Human |
|
regulation of protein transport
|
GO:0051223 |
213 |
0.166
|
Human |
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.165
|
Human |
|
nuclear transport
|
GO:0051169 |
179 |
0.157
|
Human |
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.152
|
Human |
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.151
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.143
|
Human |
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.139
|
Human |
|
negative regulation of transport
|
GO:0051051 |
176 |
0.137
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.134
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.132
|
Human |
|
negative regulation of rig i signaling pathway
|
GO:0039536 |
2 |
0.131
|
Human |
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.124
|
Human |
|
positive regulation of type i interferon production
|
GO:0032481 |
20 |
0.124
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.121
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.117
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.116
|
Human |
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.113
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.113
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.112
|
Human |
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.103
|
Human |
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.103
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.101
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.098
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.095
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.094
|
Human |
|
mda 5 signaling pathway
|
GO:0039530 |
4 |
0.094
|
Human |
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.092
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.092
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.090
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.085
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.082
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.081
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.081
|
Human |
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.081
|
Human |
|
cellular response to lipopolysaccharide
|
GO:0071222 |
57 |
0.079
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.078
|
Human |
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.077
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.077
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.075
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.071
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.070
|
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.068
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.067
|
|
|
response to dsrna
|
GO:0043331 |
25 |
0.066
|
Human |
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.065
|
Human |
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.065
|
Human |
|
rna interference
|
GO:0016246 |
4 |
0.064
|
Human |
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.063
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.063
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.061
|
Human |
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.059
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.059
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.059
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.058
|
Human |
|
positive regulation of transport
|
GO:0051050 |
336 |
0.057
|
Human |
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.056
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.055
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
46 |
0.055
|
Human |
|
detection of muramyl dipeptide
|
GO:0032498 |
1 |
0.055
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.053
|
Human |
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.053
|
Human |
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.053
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.052
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.052
|
Human |
|
single organism cellular localization
|
GO:1902580 |
332 |
0.052
|
Human |
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.049
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.048
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.047
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.047
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.046
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.046
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.046
|
Human |
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.046
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.046
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.045
|
|
|
regulation of ribonuclease activity
|
GO:0060700 |
3 |
0.044
|
|
|
cellular response to dsrna
|
GO:0071359 |
19 |
0.044
|
Human |
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.044
|
Human |
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.044
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.043
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.042
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.042
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.041
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.040
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.040
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.040
|
Human |
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.040
|
Human |
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.040
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.040
|
Human |
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.039
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.039
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.038
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.038
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.038
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
12 |
0.038
|
Human |
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.038
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
39 |
0.037
|
Human |
|
mapk cascade
|
GO:0000165 |
288 |
0.037
|
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.037
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.037
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.036
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.036
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.036
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.036
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.036
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.036
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.035
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
34 |
0.035
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.035
|
Human |
|
defense response to bacterium
|
GO:0042742 |
63 |
0.034
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.033
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.033
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.033
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.033
|
Human |
|
response to lipid
|
GO:0033993 |
206 |
0.033
|
|
|
response to exogenous dsrna
|
GO:0043330 |
10 |
0.032
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.032
|
|
|
cellular response to type i interferon
|
GO:0071357 |
12 |
0.032
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.032
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
54 |
0.032
|
Human |
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.032
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.031
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.031
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.030
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.030
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
22 |
0.030
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.030
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.030
|
|
|
cellular response to virus
|
GO:0098586 |
9 |
0.029
|
Human |
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.029
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.029
|
Human |
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.028
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.028
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.028
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.028
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.028
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.028
|
Human |
|
cellular response to lipid
|
GO:0071396 |
127 |
0.028
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
6 |
0.028
|
Human |
|
negative regulation of nucleocytoplasmic transport
|
GO:0046823 |
37 |
0.027
|
|
|
negative regulation of defense response to virus
|
GO:0050687 |
10 |
0.027
|
Human |
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.027
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.027
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.027
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.027
|
|
|
negative regulation of defense response to virus by host
|
GO:0050689 |
4 |
0.026
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.026
|
|
|
multi organism localization
|
GO:1902579 |
14 |
0.026
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.026
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.026
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
42 |
0.025
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.025
|
|
|
interferon beta production
|
GO:0032608 |
23 |
0.025
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.025
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.025
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
11 |
0.024
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.024
|
Human |
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.024
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.024
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
71 |
0.024
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.024
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.024
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.024
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.024
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.024
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.024
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.024
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.024
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.024
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.023
|
|
|
multi organism intracellular transport
|
GO:1902583 |
14 |
0.023
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.023
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.023
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.023
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.023
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.023
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.022
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.022
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
46 |
0.022
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.022
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.022
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.022
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.021
|
Human |
|
cell fate determination
|
GO:0001709 |
3 |
0.021
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.021
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.021
|
Human |
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.021
|
|
|
negative regulation of protein import into nucleus translocation
|
GO:0033159 |
3 |
0.021
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.021
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.021
|
|
|
protein import
|
GO:0017038 |
130 |
0.021
|
Human |
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.021
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.020
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.020
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.020
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.020
|
|
|
amide transport
|
GO:0042886 |
76 |
0.020
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.020
|
Human |
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.020
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.020
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.020
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.020
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.020
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.019
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.019
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.019
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.019
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.019
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.018
|
|
|
regulation of interferon beta production
|
GO:0032648 |
22 |
0.018
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.018
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.018
|
Human |
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.018
|
|
|
dna repair
|
GO:0006281 |
198 |
0.018
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.018
|
|
|
secretion
|
GO:0046903 |
254 |
0.018
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.018
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.017
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.017
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.017
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.017
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.017
|
|
|
multi organism transport
|
GO:0044766 |
14 |
0.017
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.017
|
Human |
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.017
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.017
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.017
|
|
|
transcription factor import into nucleus
|
GO:0042991 |
40 |
0.017
|
Human |
|
myoblast fusion
|
GO:0007520 |
1 |
0.016
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.016
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.016
|
Human |
|
negative regulation of protein import into nucleus
|
GO:0042308 |
30 |
0.016
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.016
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.016
|
Human |
|
dna conformation change
|
GO:0071103 |
113 |
0.016
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.016
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.016
|
|
|
positive regulation of transcription factor import into nucleus
|
GO:0042993 |
25 |
0.016
|
Human |
|
intracellular transport of viral protein in host cell
|
GO:0019060 |
4 |
0.016
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.016
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.016
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
24 |
0.016
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
22 |
0.016
|
Human |
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.016
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.015
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.015
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.015
|
Human |
|
mitochondrion organization
|
GO:0007005 |
156 |
0.015
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.015
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.015
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.015
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.015
|
|
|
protein processing
|
GO:0016485 |
226 |
0.015
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.015
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.015
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
18 |
0.015
|
|
|
cation transport
|
GO:0006812 |
331 |
0.015
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.015
|
|
|
alditol phosphate metabolic process
|
GO:0052646 |
3 |
0.014
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
3 |
0.014
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.014
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.014
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.014
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.014
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.014
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.014
|
|
|
response to type i interferon
|
GO:0034340 |
14 |
0.014
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.014
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.014
|
|
|
immune system development
|
GO:0002520 |
195 |
0.014
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.014
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.014
|
Human |
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.014
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.014
|
|
|
protein auto adp ribosylation
|
GO:0070213 |
4 |
0.014
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.014
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.014
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.014
|
Human |
|
atp metabolic process
|
GO:0046034 |
176 |
0.014
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
4 |
0.013
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.013
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.013
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.013
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.013
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.013
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.013
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.013
|
|
|
regulation of interferon alpha biosynthetic process
|
GO:0045354 |
4 |
0.013
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.013
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.013
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.013
|
|
|
cellular response to muramyl dipeptide
|
GO:0071225 |
3 |
0.013
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.013
|
|
|
type i interferon production
|
GO:0032606 |
27 |
0.013
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.013
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.013
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.013
|
|
|
positive regulation of stress activated protein kinase signaling cascade
|
GO:0070304 |
61 |
0.012
|
|
|
gene silencing by mirna
|
GO:0035195 |
23 |
0.012
|
Human |
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.012
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.012
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.012
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.012
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.012
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.012
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.012
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.012
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.012
|
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.012
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
21 |
0.012
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.012
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.012
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.012
|
|
|
negative regulation of acute inflammatory response
|
GO:0002674 |
3 |
0.012
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.012
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.012
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
48 |
0.012
|
Human |
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.012
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.012
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.012
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.011
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.011
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.011
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.011
|
|
|
regulation of response to interferon gamma
|
GO:0060330 |
7 |
0.011
|
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.011
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.011
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
2 |
0.011
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.011
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.011
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.011
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
37 |
0.011
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.011
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.011
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.011
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.011
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.011
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.011
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.011
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.011
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.011
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.011
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.011
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.011
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.011
|
|
|
regulation of type i interferon production
|
GO:0032479 |
26 |
0.010
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.010
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.010
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.010
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
35 |
0.010
|
Human |
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.010
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.010
|
|